Fiala

Peptide library › Brain & nerves

Davunetide

Also known as NAP, AL-108

In clinical trialsBrain & nerves

Experimental nasal-spray peptide studied to protect brain cells, mainly in progressive supranuclear palsy.

What people use it for

What Davunetide does in the body

An eight-amino-acid fragment of ADNP, a protein that helps keep the internal skeleton (microtubules) of nerve cells stable.

Strength of evidence

Limited: a Phase 2/3 trial in progressive supranuclear palsy found no benefit.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Nasal spray (in trials)

How long it lasts (half-life): Not well established in published data

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Davunetide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Davunetide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Brain & nerves